1 / 4

Figure SM-1: Formula developed for: (a) Acetaminophen, and (b) Erythromycin ethylsuccinate.

a. b. Figure SM-1: Formula developed for: (a) Acetaminophen, and (b) Erythromycin ethylsuccinate. a. b. c. B. B. A. A. ERY peak. A.

Download Presentation

Figure SM-1: Formula developed for: (a) Acetaminophen, and (b) Erythromycin ethylsuccinate.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. a b Figure SM-1: Formula developed for: (a) Acetaminophen, and (b) Erythromycin ethylsuccinate.

  2. a b c B B A A ERY peak A Figure SM-2: Examples of EEM fluorescence spectra: (a) at pH 7.0 ± 0.1 of S-EPS from GS-Eer, (b) with quenching effects obtained for 135 µmol/L of ACE, and (c) for 755 µmol/L of ERY. The white arrows indicate areas of interest, i.e. peaks A and B.

  3. Figure SM-3: Modeling of the fluorescence data from Figure S2 (B-EPS from GS-Eer) using the Stern-Volmer model. The F0/F curve is represented at the Ex/Em couple: 222 nm / 300 nm (aromatic protein region) (in blue), and 277 nm / 305 nm (soluble microbial by-product-like region) (in red).

  4. Table SM-1: Identification and characteristics of the drugs used in this study (Clarke, 1986; Tolls, 2001)

More Related